APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more
APT Medical Inc (688617) - Total Liabilities
Latest total liabilities as of September 2025: CN¥423.50 Million CNY
Based on the latest financial reports, APT Medical Inc (688617) has total liabilities worth CN¥423.50 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
APT Medical Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how APT Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
APT Medical Inc Competitors by Total Liabilities
The table below lists competitors of APT Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥2.56 Billion |
|
TBC Bank Group PLC
PINK:TBCCF
|
USA | $37.50 Billion |
|
Crane NXT Co
NYSE:CXT
|
USA | $1.87 Billion |
|
K&S AG
OTCQX:KPLUF
|
USA | $2.86 Billion |
|
Petronet LNG Limited
NSE:PETRONET
|
India | ₹71.22 Billion |
|
The Scotts Miracle-Gro Company
F:SCQA
|
Germany | €3.26 Billion |
|
Turkiye Sise ve Cam Fabrikalari AS
OTCGREY:TKKYY
|
USA | $237.67 Billion |
|
Alkem Laboratories Limited
NSE:ALKEM
|
India | ₹64.77 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down APT Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how APT Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for APT Medical Inc (2017–2024)
The table below shows the annual total liabilities of APT Medical Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥425.85 Million | -30.30% |
| 2023-12-31 | CN¥610.98 Million | +40.48% |
| 2022-12-31 | CN¥434.91 Million | +95.89% |
| 2021-12-31 | CN¥222.02 Million | +60.16% |
| 2020-12-31 | CN¥138.62 Million | -35.56% |
| 2019-12-31 | CN¥215.13 Million | +290.28% |
| 2018-12-31 | CN¥55.12 Million | +43.89% |
| 2017-12-31 | CN¥38.31 Million | -- |